BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 30169462)

  • 1. Antenatal treatment options for primary cytomegalovirus infections.
    Kagan KO; Sonek J; Hamprecht K
    Curr Opin Obstet Gynecol; 2018 Dec; 30(6):355-360. PubMed ID: 30169462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention and treatment of fetal cytomegalovirus infection with cytomegalovirus hyperimmune globulin: a multicenter study in Madrid.
    Blázquez-Gamero D; Galindo Izquierdo A; Del Rosal T; Baquero-Artigao F; Izquierdo Méndez N; Soriano-Ramos M; Rojo Conejo P; González-Tomé MI; García-Burguillo A; Pérez Pérez N; Sánchez V; Ramos-Amador JT; De la Calle M
    J Matern Fetal Neonatal Med; 2019 Feb; 32(4):617-625. PubMed ID: 28978246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. No evidence of obstetrical adverse events after hyperimmune globulin application for primary cytomegalovirus infection in pregnancy: experience from a single centre.
    Chiaie LD; Neuberger P; Vochem M; Lihs A; Karck U; Enders M
    Arch Gynecol Obstet; 2018 Jun; 297(6):1389-1395. PubMed ID: 29404743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fetal and maternal outcome after hyperimmunoglobulin administration for prevention of maternal-fetal transmission of cytomegalovirus during pregnancy: retrospective cohort analysis.
    Seidel V; Hackelöer M; Rancourt RC; Henrich W; Siedentopf JP
    Arch Gynecol Obstet; 2020 Dec; 302(6):1353-1359. PubMed ID: 32754858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcome of pregnancies with recent primary cytomegalovirus infection in first trimester treated with hyperimmunoglobulin: observational study.
    Kagan KO; Enders M; Hoopmann M; Geipel A; Simonini C; Berg C; Gottschalk I; Faschingbauer F; Schneider MO; Ganzenmueller T; Hamprecht K
    Ultrasound Obstet Gynecol; 2021 Apr; 57(4):560-567. PubMed ID: 33491819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Therapy or prevention of fetal infection by cytomegalovirus with immunoglobulin infusion in pregnant women with primary infection].
    Cosmi E; Mazzocco M; La Torre R; Ligi P; Sali E; Nigro G
    Acta Biomed Ateneo Parmense; 2000; 71 Suppl 1():547-51. PubMed ID: 11424804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrauterine transmission and clinical outcome of 248 pregnancies with primary cytomegalovirus infection in relation to gestational age.
    Enders G; Daiminger A; Bäder U; Exler S; Enders M
    J Clin Virol; 2011 Nov; 52(3):244-6. PubMed ID: 21820954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of maternal-fetal transmission of cytomegalovirus after primary maternal infection in the first trimester by biweekly hyperimmunoglobulin administration.
    Kagan KO; Enders M; Schampera MS; Baeumel E; Hoopmann M; Geipel A; Berg C; Goelz R; De Catte L; Wallwiener D; Brucker S; Adler SP; Jahn G; Hamprecht K
    Ultrasound Obstet Gynecol; 2019 Mar; 53(3):383-389. PubMed ID: 29947159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of cytomegalovirus hyperimmunoglobulin for prevention of congenital cytomegalovirus disease: a retrospective analysis.
    Buxmann H; Stackelberg OM; Schlößer RL; Enders G; Gonser M; Meyer-Wittkopf M; Hamprecht K; Enders M
    J Perinat Med; 2012 Mar; 40(4):439-46. PubMed ID: 22752777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperimmune globulin in pregnancy for the prevention of congenital cytomegalovirus disease.
    Nigro G
    Expert Rev Anti Infect Ther; 2017 Nov; 15(11):977-986. PubMed ID: 29072089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fetal therapies for cytomegalovirus: What we tell prospective parents.
    Bartlett AW; Hamilton ST; Shand AW; Rawlinson WD
    Prenat Diagn; 2020 Dec; 40(13):1681-1692. PubMed ID: 32271956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Revisiting short- and long-term outcome after fetal first-trimester primary cytomegalovirus infection in relation to prenatal imaging findings.
    Lipitz S; Elkan Miller T; Yinon Y; Weissbach T; De-Castro H; Hoffman C; Katorza E; Weisz B
    Ultrasound Obstet Gynecol; 2020 Oct; 56(4):572-578. PubMed ID: 31858642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First-trimester diagnosis of congenital cytomegalovirus infection after maternal primary infection in early pregnancy: feasibility study of viral genome amplification by PCR on chorionic villi obtained by CVS.
    Faure-Bardon V; Fourgeaud J; Guilleminot T; Magny JF; Salomon LJ; Bernard JP; Leruez-Ville M; Ville Y
    Ultrasound Obstet Gynecol; 2021 Apr; 57(4):568-572. PubMed ID: 33533526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening, prevention, and treatment of congenital cytomegalovirus.
    Johnson J; Anderson B
    Obstet Gynecol Clin North Am; 2014 Dec; 41(4):593-9. PubMed ID: 25454992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of maternal-fetal transmission of cytomegalovirus.
    Adler SP; Nigro G
    Clin Infect Dis; 2013 Dec; 57 Suppl 4():S189-92. PubMed ID: 24257425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Case report on early treatment with valaciclovir after maternal primary cytomegalovirus infection.
    Codaccioni C; Vauloup-Fellous C; Letamendia E; Saada J; Benachi A; Vivanti AJ
    J Gynecol Obstet Hum Reprod; 2019 Apr; 48(4):287-289. PubMed ID: 30634004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Secondary cytomegalovirus infection can cause severe fetal sequelae despite maternal preconceptional immunity.
    Zalel Y; Gilboa Y; Berkenshtat M; Yoeli R; Auslander R; Achiron R; Goldberg Y
    Ultrasound Obstet Gynecol; 2008 Apr; 31(4):417-20. PubMed ID: 18383476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytomegalovirus infection during pregnancy: state of the science.
    Leruez-Ville M; Foulon I; Pass R; Ville Y
    Am J Obstet Gynecol; 2020 Sep; 223(3):330-349. PubMed ID: 32105678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secondary prevention of congenital cytomegalovirus infection with valacyclovir following maternal primary infection in early pregnancy.
    Faure-Bardon V; Fourgeaud J; Stirnemann J; Leruez-Ville M; Ville Y
    Ultrasound Obstet Gynecol; 2021 Oct; 58(4):576-581. PubMed ID: 33998084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Placental enlargement in women with primary maternal cytomegalovirus infection is associated with fetal and neonatal disease.
    La Torre R; Nigro G; Mazzocco M; Best AM; Adler SP
    Clin Infect Dis; 2006 Oct; 43(8):994-1000. PubMed ID: 16983610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.